Regulatory Challenges
Peter discusses the regulatory challenges in testing geoprotective molecules in healthy individuals before they develop a disease, highlighting the need for a regulatory environment that accepts this risk and the lack of meaningful biomarkers of aging.In this clip
From this podcast
The Peter Attia Drive Podcast
175 - The biology of aging, rapamycin, and other interventions that target the aging process
Related Questions